Digital Pathology Market by Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), End User (Pharmaceutical Companies, Hospitals) - Global Forecast to 2025
Get in-depth analysis of the COVID-19 impact on the Digital Pathology Market
Benchmarking the rapid strategy shifts of the Top 100 companies in the Digital Pathology Market
Request For Special Pricing[168 Pages Report] The global digital pathology market is projected to reach USD 1,139 million by 2025 from USD 613 million in 2020, at a CAGR of 13.2% during the forecast period. The growth of this market is majorly attributed to the increasing adoption of digital pathology to enhance lab efficiency, rising prevalence of cancer, and the growing application of digital pathology in drug development & companion diagnostics. However, a lack of trained pathologists is expected to challenge market growth in the coming years.
The scanners segment accounted for the largest share of the digital pathology market, by product, in 2019
On the basis of product, the digital pathology market is segmented into scanners, software, communication systems, and storage systems. The scanners segment accounted for the largest share of the global digital pathology market in 2019. The large share of this segment can be attributed to the increasing adoption of digital pathology solutions across the globe.
By application, the drug discovery segment accounted for the largest market share in 2019
On the basis of application, the digital pathology market is segmented into drug discovery, disease diagnosis, teleconsultation, and training & education. The drug discovery segment accounted for the largest share of the global digital pathology market, by application, in 2019. The large share of this segment can be attributed to the growth in R&D expenditure, fueled by the need for numerous preclinical and clinical studies performed during the drug discovery and development process.
By end user, the pharmaceutical & biotechnologies segment to witness the highest growth during the forecast period
On the basis of end users, the global digital pathology market is broadly segmented into pharmaceutical & biotechnology companies, hospitals and reference laboratories, and academic & research institutes. The pharmaceutical & biotechnology companies segment accounted for the largest share of the global digital pathology market in 2019. The large share of this segment can be attributed to the increasing use of digital pathology for drug discovery studies and drug toxicology testing.
North America dominates the digital pathology market, by region, in 2019
North America accounted for the largest share of the digital pathology market in 2019. The large share of this region in the global digital pathology market can be attributed to the increasing prevalence of cancer, rising demand for quality diagnostics, the introduction of favorable reimbursement policies, and the implementation of favorable initiatives by the government in the US and Canada. The North American market is also expected to grow at the highest rate during the forecast period.
Key Market Players
The major players in the global digital pathology market are Leica Biosystems (US), Koninklijke Philips N.V. (Netherlands), Hamamatsu Photonics (Japan). Other prominent players in this market include Roche (Switzerland), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), XIFIN (US), Huron Digital Pathology (Canada), Visiopharm A/S (Denmark), Corista (US), Indica Labs (US), Objective Pathology Services (Canada), Sectra AB (Sweden), OptraSCAN (India), Glencoe Software (US), KONFOONG BIOTECH INTERNATIONAL CO., LTD (China), Inspirata, Inc. (US), Mikroscan Technologies (US), Proscia Inc. (US), Kanteron Systems (Spain).
Scope of the Report:
|
Report Metric |
Details |
|
Market size available for years |
20182024 |
|
Base year considered |
2019 |
|
Forecast period |
20202025 |
|
Forecast units |
Value (USD) |
|
Segments covered |
Product, type, application, end user and region |
|
Geographies covered |
North America, Europe, Asia, and the Rest of the World |
|
Companies covered |
Leica Biosystems (US), Koninklijke Philips (Netherlands), and Hamamatsu Photonics K.K. (Japan), Roche (Switzerland), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), XIFIN (US), Huron Digital Pathology (Canada), Visiopharm A/S (Denmark), Corista (US), Indica Labs (US), Objective Pathology Services (Canada), Sectra AB (Sweden), OptraSCAN (India), Glencoe Software (US), KONFOONG BIOTECH INTERNATIONAL CO., LTD (China), Inspirata Inc. (US), Mikroscan Technologies (US), Proscia Inc. (US), and Kanteron Systems (Spain). |
The research report categorizes the digital pathology market into the following segments and subsegments:
Product
- Scanners
- Software
- Communication Systems
- Storage Systems
Type
- Human Pathology
- Veterinary Pathology
Application
- Drug Discovery
- Disease Diagnosis
- Teleconsultation
- Training & Education
End User
- Pharmaceutical & Biotechnology Companies
- Hospitals and Reference Laboratories
- Academic & Research Institutes
Region
- North America
- Europe
- Asia Pacific
- Rest of the World
Recent Developments
- In 2019, Leica Biosystems (US) launched the Aperio GT 450
- In 2019, F. Hoffmann-La Roche Ltd (Switzerland) launched the uPath enterprise software
- In 2019, XIFIN (US) launched VisualStrata
Critical questions answered in the report:
- How will the current technological trends affect the digital pathology market in the long term?
- What are the reasons contributing to the growth of the software segment in the digital pathology market?
- Which regions are likely to grow at the highest CAGR?
- What are the challenges hindering the adoption of digital pathology solutions?
- What are the growth strategies being implemented by major market players?
Frequently Asked Questions (FAQ):
Which Digital Pathology segment to account for the largest share in 2019?
Based on product, the digital pathology market is segmented into scanners, software, communication systems, and storage systems. The scanners segment accounted for the largest share of the digital pathology market in 2019. The large share of this segment is mainly due to the increasing adoption of digital pathology solutions across the globe. However, the software segment is projected to witness the highest growth rate during the forecast period, due to the availability of user-friendly, analytical, and advanced functions for pathology diagnosis
Which is the leading end user for digital pathology market?
The end users of the digital pathology market is segmented into pharmaceutical & biotechnology companies, hospitals and reference laboratories, and academic & research institutes. In 2019, pharmaceutical & biotechnology companies accounted for the largest share of the digital pathology market. Factors contributing to the large share and high growth rate of this segment include the increasing use of digital pathology for drug discovery studies and drug toxicology testing. Biotechnology companies also use digital pathology for biobanking, biopharmaceutical studies, molecular assays, and the development of individualized medicine.
What are the opportunistic areas available for new and existing players in the digital pathology market to enhance their market share?
Developing countries such as China, India, Brazil, and Mexico are projected to offer significant growth opportunities for players operating in the digital pathology market. The huge population base, particularly in India and China, offers a sustainable market for digital pathology. Hence, a number of players in the digital pathology market are focusing on expanding their geographic presence by setting up new R&D and manufacturing facilities in developing countries.
Who are the key players operating in the global digital pathology market?
The global digital pathology market is highly competitive and fragmented. The prominent players operating in this market include Leica Biosystems (US), Koninklijke Philips (Netherlands), and Hamamatsu Photonics K.K. (Japan). Other players in this market include Roche (Switzerland), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), XIFIN (US), Huron Digital Pathology (Canada), Visiopharm A/S (Denmark), Corista (US), Indica Labs (US), Objective Pathology Services (Canada), Sectra AB (Sweden), OptraSCAN (India), Glencoe Software (US), KONFOONG BIOTECH INTERNATIONAL CO., LTD (China), Inspirata Inc. (US), Mikroscan Technologies (US), Proscia Inc. (US), and Kanteron Systems (Spain).
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Break down of primary sources
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 DIGITAL PATHOLOGY MARKET OVERVIEW
4.2 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT (2019)
4.3 GEOGRAPHICAL SNAPSHOT OF THE DIGITAL PATHOLOGY MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing adoption of digital pathology to enhance lab efficiency
5.2.1.2 Rising prevalence of cancer
5.2.1.3 Growing applications of digital pathology in drug development and companion diagnostics
5.2.1.4 Increasing initiatives by industry players
5.2.2 RESTRAINTS
5.2.2.1 High cost of digital pathology systems
5.2.3 OPPORTUNITIES
5.2.3.1 Introduction of affordable scanners for private pathology practices
5.2.3.2 Increase in demand for personalized medicines
5.2.3.3 High scope of growth in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Lack of trained pathologists
6 ARTIFICIAL INTELLIGENCE IN DIGITAL PATHOLOGY
7 DIGITAL PATHOLOGY MARKET, BY PRODUCT
7.1 INTRODUCTION
7.2 SCANNERS
7.2.1 SCANNERS ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2019
7.2.2 BRIGHTFIELD SCANNERS
7.2.3 FLUORESCENCE SCANNERS
7.2.4 OTHER SCANNERS
7.3 SOFTWARE
7.3.1 DIGITAL PATHOLOGY SOFTWARE OFFER ANALYTICAL AND HIGHLY ADVANCED FUNCTIONS NOT OFFERED BY TRADITIONAL MICROSCOPES
7.3.2 INFORMATION MANAGEMENT SOFTWARE
7.3.3 IMAGE ANALYSIS SOFTWARE
7.3.4 VISUALIZATION SOFTWARE
7.4 COMMUNICATION SYSTEMS
7.4.1 INTRODUCTION OF CLOUD-BASED COMMUNICATION SYSTEMS PROVIDES IMPETUS TO MARKET GROWTH
7.5 STORAGE SYSTEMS
7.5.1 APPLICATION OF PACS AND VNA TO DRIVE THE STORAGE SYSTEMS MARKET
8 DIGITAL PATHOLOGY MARKET, BY TYPE
8.1 INTRODUCTION
8.2 HUMAN PATHOLOGY
8.2.1 HUMAN PATHOLOGY SEGMENT HELD THE LARGEST SHARE OF THE MARKET IN 2019
8.3 VETERINARY PATHOLOGY
8.3.1 VETERINARY DIGITAL PATHOLOGY CUTS THE TURNAROUND TIME FOR ANIMAL DISEASE DIAGNOSISA KEY FACTOR DRIVING MARKET GROWTH
9 DIGITAL PATHOLOGY MARKET, BY APPLICATION
9.1 INTRODUCTION
9.2 DRUG DISCOVERY
9.2.1 INCREASES IN R&D SPENDING WILL PROVIDE IMPETUS TO DRUG DISCOVERY SEGMENT DURING THE FORECAST PERIOD.
9.3 DISEASE DIAGNOSIS
9.3.1 DISEASE DIAGNOSIS SEGMENT TO REGISTER STEADY GROWTH DURING THE FORECAST PERIOD.
9.4 TELECONSULTATION
9.4.1 THE NEED FOR ACCURATE, EFFICIENT, AND QUICK DIAGNOSIS IS EXPECTED TO DRIVE THE TELECONSULTATION MARKET DURING THE FORECAST PERIOD
9.5 TRAINING & EDUCATION
9.5.1 DIGITAL PATHOLOGY CAN IMPROVE DISTRIBUTION OF RARE AND EDUCATIONAL CASES FOR TRAINING
10 DIGITAL PATHOLOGY MARKET, BY END USER
10.1 INTRODUCTION
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT IS ESTIMATED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST
10.3 HOSPITALS & REFERENCE LABORATORIES
10.3.1 INCREASING ADOPTION OF DIGITAL PATHOLOGY SOLUTIONS IN HOSPITALS TO DRIVE THE GROWTH OF THIS END-USER SEGMENT
10.4 ACADEMIC & RESEARCH INSTITUTES
10.4.1 ACADEMIC & RESEARCH INSTITUTES SEGMENT TO REGISTER STEADY GROWTH DURING THE FORECAST PERIOD
11 GLOBAL DIGITAL PATHOLOGY MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 US
11.2.1.1 Favorable reimbursement scenario for digital pathology in the US
11.2.2 CANADA
11.2.2.1 Growing need for high-quality cancer diagnosis and government initiatives to drive the market growth in Canada
11.3 EUROPE
11.3.1 UK
11.3.1.1 The UK to account for the largest share in the European market
11.3.2 GERMANY
11.3.2.1 High healthcare expenditure and supportive health insurance to drive the market growth in Germany
11.3.3 SWEDEN
11.3.3.1 Increasing government initiatives and deployment of digital pathology solutions
11.3.4 DENMARK
11.3.4.1 High cancer prevalence to drive the market growth in Denmark
11.3.5 FRANCE
11.3.5.1 Increasing incidences of cancer to drive the market growth during the forecast period
11.3.6 REST OF EUROPE (ROE)
11.3.6.1 Integration & deployment of digital pathology solutions in Rest of Europe
11.4 ASIA PACIFIC
11.4.1 CHINA
11.4.1.1 Favorable initiatives for the adoption of telepathology in China
11.4.2 JAPAN
11.4.2.1 Initiatives are taken by industry players for cancer diagnosis
11.4.3 INDIA
11.4.3.1 Increasing incidences of cancer in India to drive the market growth
11.4.4 REST OF ASIA PACIFIC (ROAPAC)
11.5 REST OF THE WORLD
11.5.1 LATIN AMERICA
11.5.1.1 Increase in purchasing power and healthcare affordability to drive the market growth in LATAM countries
11.5.2 MIDDLE EAST AND AFRICA
11.5.2.1 Potential for the growth of the digital pathology market in this region
12 COMPETITIVE LANDSCAPE
12.1 INTRODUCTION
12.2 MARKET SHARE ANALYSIS
12.3 COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET) (2019)
12.3.1 VISIONARY LEADERS
12.3.2 INNOVATORS
12.3.3 DYNAMIC DIFFERENTIATORS
12.3.4 EMERGING COMPANIES
12.4 COMPETITIVE SCENARIO
12.4.1 KEY DEVELOPMENTS IN THE DIGITAL PATHOLOGY MARKET
12.4.2 KEY PRODUCT LAUNCHES
12.4.3 KEY ACQUISITIONS
12.4.4 KEY EXPANSIONS
13 COMPANY PROFILES
(Business overview, Products offered, Recent developments, Competitive analysis)*
13.1 LEICA BIOSYSTEMS (SUBSIDIARY OF DANAHER CORPORATION)
13.2 KONINKLIJKE PHILIPS
13.3 HAMAMATSU PHOTONICS
13.4 F. HOFFMANN-LA ROCHE LTD
13.5 SECTRA AB
13.6 3DHISTECH
13.7 APOLLO ENTERPRISE IMAGING
13.8 XIFIN, INC.
13.9 HURON DIGITAL PATHOLOGY
13.10 VISIOPHARM
13.11 CORISTA
13.12 INDICA LABS
13.13 OBJECTIVE PATHOLOGY SERVICES
13.14 OPTRASCAN, INC.
13.15 GLENCOE SOFTWARE, INC.
13.16 OTHER COMPANIES
13.16.1 KONFOONG BIOTECH INTERNATIONAL CO., LTD
13.16.2 INSPIRATA, INC.
13.16.3 MIKROSCAN TECHNOLOGIES, INC.
13.16.4 PROSCIA INC
13.16.5 KANTERON SYSTEMS
*Business overview, Products offered, Recent developments, Competitive analysis might not be captured in case of unlisted companies.
14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL
14.3 AVAILABLE CUSTOMIZATIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
LIST OF TABLES (159 Tables)
TABLE 1 GLOBAL CANCER INCIDENCE, 2018 VS. 2025
TABLE 2 GROWTH IN THE NUMBER OF PERSONALIZED MEDICINES, 20082016
TABLE 3 NUMBER OF PATHOLOGISTS PER 100,000 POPULATION, BY COUNTRY, 2018
TABLE 4 DIGITAL PATHOLOGY AI MARKET, BY REGION, 20182025 (MILLION)
TABLE 5 DIGITAL PATHOLOGY MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 6 SCANNING MAGNIFICATION AND APPLICATIONS
TABLE 7 DIGITAL PATHOLOGY SCANNERS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 8 DIGITAL PATHOLOGY SCANNERS MARKET, BY REGION, 20182025 (UNITS)
TABLE 9 DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 10 BRIGHTFIELD SCANNERS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 11 FLUORESCENCE SCANNERS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 12 OTHER SCANNERS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 13 TYPES OF DIGITAL PATHOLOGY SOFTWARE
TABLE 14 DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 15 INFORMATION MANAGEMENT SOFTWARE MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 16 IMAGE ANALYSIS SOFTWARE MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 17 VISUALIZATION SOFTWARE MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 18 COMMUNICATION SYSTEMS USED IN DIGITAL PATHOLOGY
TABLE 19 DIGITAL PATHOLOGY COMMUNICATION SYSTEMS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 20 DIGITAL PATHOLOGY STORAGE SYSTEMS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 21 DIGITAL PATHOLOGY MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 22 HUMAN DIGITAL PATHOLOGY MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 23 VETERINARY DIGITAL PATHOLOGY MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 24 DIGITAL PATHOLOGY MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 25 APPLICATIONS OF DIGITAL PATHOLOGY IN DRUG DISCOVERY/RESEARCH:
TABLE 26 DIGITAL PATHOLOGY MARKET FOR DRUG DISCOVERY, BY REGION, 20182025 (USD MILLION)
TABLE 27 DIGITAL PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY REGION, 20182025 (USD MILLION)
TABLE 28 DIGITAL PATHOLOGY MARKET FOR TELECONSULTATION, BY REGION, 20182025 (USD MILLION)
TABLE 29 DIGITAL PATHOLOGY MARKET FOR TRAINING & EDUCATION, BY REGION, 20182025 (USD MILLION)
TABLE 30 DIGITAL PATHOLOGY MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 31 DIGITAL PATHOLOGY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 20182025 (USD MILLION)
TABLE 32 HOSPITAL DEPLOYMENT OF DIGITAL PATHOLOGY SOLUTIONS
TABLE 33 DIGITAL PATHOLOGY MARKET FOR HOSPITALS & REFERENCE LABORATORIES, BY REGION, 20182025 (USD MILLION)
TABLE 34 DIGITAL PATHOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 20182025 (USD MILLION)
TABLE 35 DIGITAL PATHOLOGY MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 36 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 20182025 (USD MILLION)
TABLE 37 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 38 NORTH AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 39 NORTH AMERICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 40 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 41 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 42 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 43 CANCER CASES IN THE US, 2018
TABLE 44 CONFERENCES/MEETINGS/COURSES/WORKSHOPS HELD/TO BE HELD IN THE US
TABLE 45 US: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 46 US: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 47 US: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 48 US: DIGITAL PATHOLOGY MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 49 US: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 50 US: DIGITAL PATHOLOGY MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 51 CANADA: DIGITAL PATHOLOGY INITIATIVES AND FUNDING
TABLE 52 CANADA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 53 CANADA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 54 CANADA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 55 CANADA: DIGITAL PATHOLOGY MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 56 CANADA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 57 CANADA: DIGITAL PATHOLOGY MARKET, BY END USER, 20182025(USD MILLION)
TABLE 58 EUROPE: DIGITAL PATHOLOGY MARKET, BY COUNTRY/REGION, 20182025 (USD MILLION)
TABLE 59 EUROPE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 60 EUROPE: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 61 EUROPE: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 62 EUROPE: DIGITAL PATHOLOGY MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 63 EUROPE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 64 EUROPE: DIGITAL PATHOLOGY MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 65 CONFERENCES/COURSES HELD/TO BE HELD IN THE UK
TABLE 66 UK: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 67 UK: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 68 UK: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 69 UK: DIGITAL PATHOLOGY MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 70 UK: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 71 UK: DIGITAL PATHOLOGY MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 72 CANCER INCIDENCE, BY TYPE, 2018 VS. 2025
TABLE 73 GERMANY: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 74 GERMANY: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 75 GERMANY: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 76 GERMANY: DIGITAL PATHOLOGY MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 77 GERMANY: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 78 GERMANY: DIGITAL PATHOLOGY MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 79 CANCER CASES IN SWEDEN, 2018
TABLE 80 SWEDEN: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 20182025(USD MILLION)
TABLE 81 SWEDEN: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 82 SWEDEN: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 83 SWEDEN: DIGITAL PATHOLOGY MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 84 SWEDEN: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 85 SWEDEN: DIGITAL PATHOLOGY MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 86 DENMARK: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 87 DENMARK: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 88 DENMARK: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 89 DENMARK: DIGITAL PATHOLOGY MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 90 DENMARK: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 91 DENMARK: DIGITAL PATHOLOGY MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 92 CANCER INCIDENCE, BY TYPE, 2018 VS. 2025
TABLE 93 FRANCE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 94 FRANCE: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 95 FRANCE: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 96 FRANCE: DIGITAL PATHOLOGY MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 97 FRANCE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 98 FRANCE: DIGITAL PATHOLOGY MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 99 ROE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 100 ROE: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 101 ROE: DIGITAL PATHOLOGY SOFTWARE MARKET, BY SOFTWARE, 20182025 (USD MILLION)
TABLE 102 ROE: DIGITAL PATHOLOGY MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 103 ROE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 104 ROE: DIGITAL PATHOLOGY MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 105 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 20182025 (USD MILLION)
TABLE 106 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 107 ASIA PACIFIC: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 108 ASIA PACIFIC: DIGITAL PATHOLOGY SOFTWARE MARKET, BY SOFTWARE, 20182025 (USD MILLION)
TABLE 109 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 110 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 111 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 112 CANCER CASES IN CHINA, 2018
TABLE 113 CHINA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 114 CHINA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 115 CHINA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 116 CHINA: DIGITAL PATHOLOGY MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 117 CHINA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 118 CHINA: DIGITAL PATHOLOGY MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 119 JAPAN: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 120 JAPAN: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 121 JAPAN: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 122 JAPAN: DIGITAL PATHOLOGY MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 123 JAPAN: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 124 JAPAN: DIGITAL PATHOLOGY MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 125 INDIA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 126 INDIA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 127 INDIA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 128 INDIA: DIGITAL PATHOLOGY MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 129 INDIA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 130 INDIA: DIGITAL PATHOLOGY MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 131 ROAPAC: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 132 ROAPAC: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 133 ROAPAC: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 134 ROAPAC: DIGITAL PATHOLOGY MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 135 ROAPAC: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 136 ROAPAC: DIGITAL PATHOLOGY MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 137 ROW: DIGITAL PATHOLOGY MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 138 ROW: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 139 ROW: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 140 ROW: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 141 ROW: DIGITAL PATHOLOGY MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 142 ROW: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 143 ROW: DIGITAL PATHOLOGY MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 144 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 145 LATIN AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 146 LATIN AMERICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 147 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 148 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 149 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 150 MIDDLE EAST AND AFRICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 151 MIDDLE EAST AND AFRICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 152 MIDDLE EAST AND AFRICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 153 MIDDLE EAST AND AFRICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 154 MIDDLE EAST AND AFRICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 155 MIDDLE EAST AND AFRICA: DIGITAL PATHOLOGY MARKET, BY END USER, 20182025 (USD MILLION)
TABLE 156 PARTNERSHIPS AND COLLABORATIONS (20162019)
TABLE 157 PRODUCT LAUNCHES (20162019)
TABLE 158 ACQUISITIONS (20162019)
TABLE 159 EXPANSIONS (20162019)
LIST OF FIGURES (26 Figures)
FIGURE 1 RESEARCH DESIGN
FIGURE 2 PRIMARY SOURCES
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY CATEGORY, DESIGNATION, AND REGION
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 5 ILLUSTRATIVE EXAMPLE OF LEICA BIOSYSTEMS (SUBSIDIARY OF DANAHER CORPORATION)
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 DIGITAL PATHOLOGY MARKET ANALYSIS, BY PRODUCT (2020)
FIGURE 8 DIGITAL PATHOLOGY MARKET ANALYSIS, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 9 DIGITAL PATHOLOGY MARKET ANALYSIS, BY APPLICATION, 2020 VS. 2025, (USD MILLION)
FIGURE 10 DIGITAL PATHOLOGY MARKET ANALYSIS, BY END USER, 2020 VS. 2025, (USD MILLION)
FIGURE 11 NORTH AMERICA MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 12 INCREASING ADOPTION OF DIGITAL PATHOLOGY SOLUTIONS TO DRIVE THE MARKET
FIGURE 13 SCANNERS ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN DIGITAL PATHOLOGY MARKET IN 2019
FIGURE 14 NORTH AMERICA TO WITNESS THE HIGHEST GROWTH IN THE DIGITAL PATHOLOGY MARKET FROM 2020 TO 2025
FIGURE 15 DIGITAL PATHOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 16 DIGITAL PATHOLOGY MARKET, BY REGION, 2019
FIGURE 17 NORTH AMERICA: DIGITAL PATHOLOGY MARKET SNAPSHOT
FIGURE 18 EUROPE: DIGITAL PATHOLOGY MARKET SNAPSHOT
FIGURE 19 CANCER PREVALENCE IN DENMARK
FIGURE 20 VALUE-BASED MARKET SHARES OF KEY PLAYERS, 2019
FIGURE 21 DIGITAL PATHOLOGY MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2019
FIGURE 22 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
FIGURE 23 KONINKLIJKE PHILIPS: COMPANY SNAPSHOT (2019)
FIGURE 24 HAMAMATSU PHOTONICS: COMPANY SNAPSHOT (2019)
FIGURE 25 F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT (2019)
FIGURE 26 SECTRA AB: COMPANY SNAPSHOT (2018)
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, key players, competitive landscape, key market dynamics, and key player strategies.
Secondary Research
The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the digital pathology market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the digital pathology market. The primary sources from the demand side included industry experts, purchase & sales managers, doctors, and personnel from research organizations. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by product, type, application, end user, and region).
Data Triangulation
After arriving at the market size, the digital pathology market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments.
Objectives of the Study
- To define, describe, and forecast the global digital pathology market by product, type, application, end user, and region
- To provide detailed information about the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall digital pathology market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the digital pathology market in four major regions along with their respective key countries (North America, Europe, Asia, and the Rest of the World)
- To profile the key players in the global digital pathology market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments such as product launches, expansions, and R&D activities of the leading players in the digital pathology market.
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the companys specific needs. The following customization options are available for the report:
Geographic Analysis
- Further breakdown of the digital pathology market into South Korea, New Zealand, and other Southeast Asian countries
- Further breakdown of the European digital pathology market into Italy, Spain, Belgium, and the Netherlands.
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Digital Pathology Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Digital Pathology Market